Q1 2024
Released May 9, 2024, after the close
10-Q filed May 9, 2024, 39 days after period end · 0000950170-24-056996
Q1 2024 · 10-Q
Revenue—
Net Income-$2.75M-$2.75M no prior Q1 2023 on fileN/M vs Q4 2023
EPS Diluted-$0.06-$0.06 no prior Q1 2023 on fileno prior Q4 2023 on file
Operating Income-$3,135,993—
Operating Cash Flow-$3,868,248—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2024 | Q1 2022 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$2.75M | -$4.03M | -$2.71M | -$4.70M |
| EPS Diluted | -$0.06 | -$0.08 | -$0.06 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR